Show simple item record

Comparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwp

dc.contributor.authorDuque-Afonso, J.
dc.contributor.authorFinke, J.
dc.contributor.authorNgoya, M.
dc.contributor.authorLabopin, M.
dc.contributor.authorNicholson, E.
dc.contributor.authorKottaridis, P.
dc.contributor.authorCraddock, C.
dc.contributor.authorTholouli, E.
dc.contributor.authorProtheroe, R.
dc.contributor.authorWagner-Drouet, E. M.
dc.contributor.authorBloor, Adrian
dc.contributor.authorValerius, T.
dc.contributor.authorWilson, K. M. O.
dc.contributor.authorSavani, B. N.
dc.contributor.authorSpyridonidis, A.
dc.contributor.authorNagler, A.
dc.contributor.authorMohty, M.
dc.date.accessioned2023-01-16T14:12:57Z
dc.date.available2023-01-16T14:12:57Z
dc.date.issued2022en
dc.identifier.citationDuque-Afonso J, Finke J, Ngoya M, Labopin M, Nicholson E, Kottaridis P, et al. Comparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwp. Bone marrow transplantation. 2022 Nov;57(SUPPL 1):164-5. PubMed PMID: WOS:000878153300253.en
dc.identifier.urihttp://hdl.handle.net/10541/625901
dc.language.isoenen
dc.titleComparison of fludarabine/melphalan(flumel) with fludarabine/melphalan/bcnu or thiotepa(fbm/ftm) in patients with AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the ebmt alwpen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Freiburg/Klinik für Innere Medizin I, Freiburg, Germanyen
dc.identifier.journalBone Marrow Transplantationen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record